Stoke advances Phase 3 Dravet trial toward mid-2027 data, posts $50M Q1 loss on lower revenue
Filed May 7, 2026 · Period ending March 31, 2026 · Compared to 10-Q May 13, 2025 · ~2 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade STOK commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 5, 2026 4:34 PM